BioCentury | Oct 8, 2020
Finance

Data Bytes: RADx funding recipients

...tests. A study published in medRxiv this week by Becton Dickinson and Co. (NYSE:BDX) and Johns Hopkins University...
BioCentury | Oct 7, 2020
Product Development

Antigen tests outshine PCR at predicting who can transmit SARS-CoV-2

...work from Becton Dickinson and Co. (NYSE:BDX) and Johns Hopkins University...
...for RNA detection tests. Sandi Wong Becton Dickinson and Co. Johns Hopkins University NIH COVID-19 cov19dx cov19sci CHS2020 Veritor Lyra Rapid...
BioCentury | Oct 6, 2020
Product Development

Warp Speed asking biopharmas to delay seeking EUA until they have enough doses

...is authorized.Speaking at a symposium organized by Johns Hopkins University...
BioCentury | Oct 6, 2020
Regulation

White House allows FDA to release long-awaited COVID vaccine EUA guidance

...Tuesday at a virtual symposium organized by Johns Hopkins University...
BioCentury | Sep 4, 2020
Regulation

A glimpse at FDA’s vaccine panel ahead of October’s COVID-19 meeting

...Phase III trials conclude. “Fully disagree,” he tweeted, responding to a Forbes blog written by Johns Hopkins University...
BioCentury | Jul 21, 2020
Regulation

First EUA for pooled COVID-19 test points to effect of prevalence on performance

...Arizona grew from around 10% in early June to over 23% in mid-July, according to Johns Hopkins University’s...
BioCentury | Jun 24, 2020
Finance

AsclepiX aims for basket of retinal indications with $35M series A

...disease indications, while also developing peptides into therapeutic candidates for oncology. Spun out of The Johns Hopkins University...
BioCentury | Jun 20, 2020
Translation in Brief

CAR Ts against senescent cells; plus NIH program for ALS, sex-dependent COVID-19 immune responses and more

...0.16 μg/mL. BridgeBio, Johns Hopkins gene therapy collaboration BridgeBio Pharma Inc. (NASDAQ:BBIO) has partnered with Johns Hopkins University...
...TNF)-related apoptosis-inducing ligand BioCentury Staff Memorial Sloan Kettering Cancer Center Scripps Research National Institutes of Health University of Amsterdam BridgeBio Pharma Inc. Johns Hopkins University Plasminogen...
BioCentury | Jun 4, 2020
Product Development

WHO restarts hydroxychloroquine testing as drug fails another COVID-19 trial

...partner with HHS and clinical organizations to support data analysis. At least 15 institutions including Johns Hopkins University...
BioCentury | Apr 29, 2020
Product Development

Thrive AACR data highlights specificity, sensitivity trade-offs for cancer screening

...at the American Association for Cancer Research (AACR) 2020 virtual meeting. The study, conducted with Johns Hopkins University...
...cancer (see “Wave of Enthusiasm in Disease Detection” ). Karen Tkach Tuzman, Associate Editor Thrive Earlier Detection Corp. Johns Hopkins University Geisinger...
Items per page:
1 - 10 of 881
BioCentury | Oct 8, 2020
Finance

Data Bytes: RADx funding recipients

...tests. A study published in medRxiv this week by Becton Dickinson and Co. (NYSE:BDX) and Johns Hopkins University...
BioCentury | Oct 7, 2020
Product Development

Antigen tests outshine PCR at predicting who can transmit SARS-CoV-2

...work from Becton Dickinson and Co. (NYSE:BDX) and Johns Hopkins University...
...for RNA detection tests. Sandi Wong Becton Dickinson and Co. Johns Hopkins University NIH COVID-19 cov19dx cov19sci CHS2020 Veritor Lyra Rapid...
BioCentury | Oct 6, 2020
Product Development

Warp Speed asking biopharmas to delay seeking EUA until they have enough doses

...is authorized.Speaking at a symposium organized by Johns Hopkins University...
BioCentury | Oct 6, 2020
Regulation

White House allows FDA to release long-awaited COVID vaccine EUA guidance

...Tuesday at a virtual symposium organized by Johns Hopkins University...
BioCentury | Sep 4, 2020
Regulation

A glimpse at FDA’s vaccine panel ahead of October’s COVID-19 meeting

...Phase III trials conclude. “Fully disagree,” he tweeted, responding to a Forbes blog written by Johns Hopkins University...
BioCentury | Jul 21, 2020
Regulation

First EUA for pooled COVID-19 test points to effect of prevalence on performance

...Arizona grew from around 10% in early June to over 23% in mid-July, according to Johns Hopkins University’s...
BioCentury | Jun 24, 2020
Finance

AsclepiX aims for basket of retinal indications with $35M series A

...disease indications, while also developing peptides into therapeutic candidates for oncology. Spun out of The Johns Hopkins University...
BioCentury | Jun 20, 2020
Translation in Brief

CAR Ts against senescent cells; plus NIH program for ALS, sex-dependent COVID-19 immune responses and more

...0.16 μg/mL. BridgeBio, Johns Hopkins gene therapy collaboration BridgeBio Pharma Inc. (NASDAQ:BBIO) has partnered with Johns Hopkins University...
...TNF)-related apoptosis-inducing ligand BioCentury Staff Memorial Sloan Kettering Cancer Center Scripps Research National Institutes of Health University of Amsterdam BridgeBio Pharma Inc. Johns Hopkins University Plasminogen...
BioCentury | Jun 4, 2020
Product Development

WHO restarts hydroxychloroquine testing as drug fails another COVID-19 trial

...partner with HHS and clinical organizations to support data analysis. At least 15 institutions including Johns Hopkins University...
BioCentury | Apr 29, 2020
Product Development

Thrive AACR data highlights specificity, sensitivity trade-offs for cancer screening

...at the American Association for Cancer Research (AACR) 2020 virtual meeting. The study, conducted with Johns Hopkins University...
...cancer (see “Wave of Enthusiasm in Disease Detection” ). Karen Tkach Tuzman, Associate Editor Thrive Earlier Detection Corp. Johns Hopkins University Geisinger...
Items per page:
1 - 10 of 881